BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 19-Dec-2016

The Company has informed that it has credited the Bonus shares for the 15 months period ended on June 30, 2016 to the respective shareholders' BO accounts on December 19, 2016.

SQURPHARMA 14-Nov-2016

Trading of the shares of the Company will resume on 15.11.2016 after record date.

SQURPHARMA 14-Nov-2016

(Q1 Un-audited): Consolidated EPS was Tk. 3.89 for July-September, 2016 as against Tk. 3.18 for July-September, 2015; Consolidated NOCFPS was Tk. 5.67 for July-September, 2016 as against Tk. 4.03 for July-September, 2015. Consolidated NAV per share was Tk. 69.17 as of September 30, 2016 and Tk. 65.04 as of June 30, 2016.

SQURPHARMA 13-Nov-2016

Trading of the shares of the Company will remain suspended on record date i.e., 14.11.2016.

SQURPHARMA 09-Nov-2016

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 10.11.2016 to 13.11.2016. Trading of the shares of the Company will remain suspended on record date i.e., 14.11.2016.

SQURPHARMA 08-Nov-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2016 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.

SQURPHARMA 17-Oct-2016

There will be no price limit on the trading of the shares of the Company today (17.10.2016) following its corporate declaration.

SQURPHARMA 17-Oct-2016

(continuation news of SQURPHARMA): The Company has also reported EPS of Tk. 14.80, NAV per share of Tk. 57.08 and NOCFPS of Tk. 15.88 for the 15 months period ended on June 30, 2016 which was Tk. 10.46, Tk. 44.95 and Tk. 12.21 respectively for 15 months period from Jan 2014 to March 2015. (end)

SQURPHARMA 17-Oct-2016

The Board of Directors has recommended 40% cash and 10% stock dividend for the 15 months period from April 01, 2015 to June 30, 2016. The Board has also approved Tk. 250.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 13.12.2016, Time: 10:00 AM, Venue: Raowa Convention Hall-2, Mohakhali, DOHS, Dhaka. Record Date: 14.11.2016. (cont.)

SQURPHARMA 09-Oct-2016

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 16, 2016 at 3:30 PM to consider, among others, audited financial statements of the Company for the 15 months period from April 01, 2015 to June 30, 2016.

Previous Next page